Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 5146 AL 5160

Pitfalls and Artifacts of (123)I-Ioflupane SPECT in Parkinsonian Syndromes: A Quality Improvement Teaching Tool

Tuma Santos CA, Wallace WD, Kim S, Vijayakumar V.

J Nucl Med Technol. 2021 Jun;49(2):114-119. doi: 10.2967/jnmt.120.258491. Epub 2020 Dec 24.

Imaging Transcriptomics in Neurodegenerative Diseases

Mroczek M, Desouky A, Sirry W.

J Neuroimaging. 2021 Mar;31(2):244-250. doi: 10.1111/jon.12827. Epub 2020 Dec 26.

Freezing of Gait in Parkinson's Disease: Invasive and Noninvasive Neuromodulation

Rahimpour S, Gaztanaga W, Yadav AP, Chang SJ, Krucoff MO, Cajigas I, Turner DA, Wang DD.

Neuromodulation. 2021 Jul;24(5):829-842. doi: 10.1111/ner.13347. Epub 2020 Dec 26.

Quality of life in Parkinson's disease: A systematic review and meta-analysis of comparative studies

Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari GS, Zang YF, Xiang YT.

CNS Neurosci Ther. 2021 Mar;27(3):270-279. doi: 10.1111/cns.13549. Epub 2020 Dec 28.

Association of Multiple Dopamine D3 Receptor Gene 3'UTR Polymorphisms with Susceptibility to Parkinson's Disease and Clinical Efficacy of Piribedil Therapy

Zhang R, Li J, Wu Y, Liang S, Xu L.

Genet Test Mol Biomarkers. 2021 Jan;25(1):20-30. doi: 10.1089/gtmb.2020.0195. Epub 2020 Dec 28.

Targeting mitophagy in Parkinson's disease

Clark EH, Vázquez de la Torre A, Hoshikawa T, Briston T.

J Biol Chem. 2021 Jan-Jun;296:100209. doi: 10.1074/jbc.REV120.014294. Epub 2020 Dec 24.

Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disorders

Rusz J, Tykalova T, Ramig LO, Tripoliti E.

Mov Disord. 2021 Apr;36(4):803-814. doi: 10.1002/mds.28465. Epub 2020 Dec 29.

Interactions of α-synuclein oligomers with lipid membranes

Musteikytė G, Jayaram AK, Xu CK, Vendruscolo M, Krainer G, Knowles TPJ.

Biochim Biophys Acta Biomembr. 2021 Apr 1;1863(4):183536. doi: 10.1016/j.bbamem.2020.183536. Epub 2020 Dec 26.

Consensus Guidelines on Rodent Models of Restless Legs Syndrome

Salminen AV, Silvani A, Allen RP, Clemens S, Garcia-Borreguero D, Ghorayeb I, Ferré S, Li Y, Ondo W, Picchietti DL, Rye D, Siegel JM, Winkelman JW, Manconi M; International Restless Legs Syndrome Study Group (IRLSSG).

Mov Disord. 2021 Mar;36(3):558-569. doi: 10.1002/mds.28401. Epub 2020 Dec 31.

Efficacy of Vestibular Rehabilitation in Patients With Neurologic Disorders: A Systematic Review

Tramontano M, Russo V, Spitoni GF, Ciancarelli I, Paolucci S, Manzari L, Morone G.

Arch Phys Med Rehabil. 2021 Jul;102(7):1379-1389. doi: 10.1016/j.apmr.2020.11.017. Epub 2020 Dec 28.

Functional relevance of resistance training-induced neuroplasticity in health and disease

Hortobágyi T, Granacher U, Fernandez-Del-Olmo M, Howatson G, Manca A, Deriu F, Taube W, Gruber M, Márquez G, Lundbye-Jensen J, Colomer-Poveda D.

Neurosci Biobehav Rev. 2021 Mar;122:79-91. doi: 10.1016/j.neubiorev.2020.12.019. Epub 2020 Dec 28.

Research on developing drugs for Parkinson's disease

Zhang CL, Han QW, Chen NH, Yuan YH.

Brain Res Bull. 2021 Mar;168:100-109. doi: 10.1016/j.brainresbull.2020.12.017. Epub 2020 Dec 30.

Safinamide in neurological disorders and beyond: Evidence from preclinical and clinical studies

Wasan H, Singh D, Kh R.

Brain Res Bull. 2021 Mar;168:165-177. doi: 10.1016/j.brainresbull.2020.12.018. Epub 2020 Dec 30.

Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study

Bullock A, Kaul I, Li S, Silber C, Doherty J, Kanes SJ.

J Neurol Sci. 2021 Feb 15;421:117277. doi: 10.1016/j.jns.2020.117277. Epub 2020 Dec 20.

Polydopamine-based nanomaterials and their potentials in advanced drug delivery and therapy

Li H, Yin D, Li W, Tang Q, Zou L, Peng Q.

Colloids Surf B Biointerfaces. 2021 Mar;199:111502. doi: 10.1016/j.colsurfb.2020.111502. Epub 2020 Dec 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias